Open AccessA meta-analysis of adoptive immunotherapy in postoperative hepatocellular carcinoma
Author(s) -
Hui Zhao,
Min Zheng,
Kun Wang,
Lianmin Wang,
Haiyu He,
Meilian Wang,
Yanmei Shi,
Songquan Huang,
Fengming Ji,
Xiao Li,
Hong Zhu,
Lin Wang,
Xiaowen Zhang,
Xueyang Shi,
Songling Zhao,
FU BiMang,
Tao Wu
Publication year - 2018
Publication title -
journal of cancer research and therapeutics/journal of cancer research and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.475
H-Index - 39
eISSN - 0973-1482
pISSN - 1998-4138
DOI - 10.4103/jcrt.jcrt_858_17
Subject(s) - medicine , hepatocellular carcinoma , gastroenterology , relative risk , confidence interval , adjuvant , randomized controlled trial , meta analysis , immunotherapy , adjuvant therapy , adoptive immunotherapy , surgery , cancer
Adoptive immunotherapy (AIT) has been adopted as an adjuvant treatment for hepatocellular carcinoma (HCC) patients after curative therapy. However, the outcomes of AIT remain controversial.